257 related articles for article (PubMed ID: 1372464)
21. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
22. Staging and therapy of orbital lymphomas.
Bennett CL; Putterman A; Bitran JD; Recant W; Shapiro CM; Karesh J; Kalokhe U
Cancer; 1986 Mar; 57(6):1204-8. PubMed ID: 3484664
[TBL] [Abstract][Full Text] [Related]
23. Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphoma.
Siegel RD; Skarin AT; Canellos GP
Am J Clin Oncol; 1986 Oct; 9(5):420-3. PubMed ID: 2430447
[TBL] [Abstract][Full Text] [Related]
24. Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
Baer MR; Stein RS; Greer JP; Wolff SN; Hainsworth JD; Flexner JM
Cancer Treat Rep; 1986 Jun; 70(6):785-7. PubMed ID: 3488125
[TBL] [Abstract][Full Text] [Related]
25. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Sweetenham JW; Mead GM; Whitehouse JM
J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
[TBL] [Abstract][Full Text] [Related]
26. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
Ann Oncol; 1994; 5 Suppl 2():91-5. PubMed ID: 7515652
[TBL] [Abstract][Full Text] [Related]
27. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Konopka L; Pawelski S
J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
[No Abstract] [Full Text] [Related]
28. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD
Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861
[TBL] [Abstract][Full Text] [Related]
29. The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Hoppe RT
Cancer; 1985 May; 55(9 Suppl):2176-83. PubMed ID: 2579725
[TBL] [Abstract][Full Text] [Related]
30. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
31. Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Oguchi M; Izuno I; Takei K; Shikama N; Sasaki S; Gomi K; Sone S
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):87-92. PubMed ID: 9054881
[TBL] [Abstract][Full Text] [Related]
32. Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Fisher RI
Cancer; 1994 Nov; 74(9 Suppl):2657-61. PubMed ID: 7525045
[TBL] [Abstract][Full Text] [Related]
33. Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Waits TM; Greco FA; Greer JP; Hainsworth JD
Leuk Lymphoma; 1993 Aug; 10(6):453-9. PubMed ID: 7691308
[TBL] [Abstract][Full Text] [Related]
34. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
35. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
[No Abstract] [Full Text] [Related]
36. Management of advanced stage intermediate grade non-Hodgkin's lymphomas.
Liang RH; Chiu EK; Chan TK; Todd D; Loke SL
Hematol Oncol; 1990; 8(3):147-54. PubMed ID: 1695608
[TBL] [Abstract][Full Text] [Related]
37. Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology.
Gherlinzoni F; Guglielmi C; Mazza P; Amadori S; Mandelli F; Tura S
Semin Oncol; 1990 Dec; 17(6 Suppl 10):3-8; discussion 8-9. PubMed ID: 1701924
[TBL] [Abstract][Full Text] [Related]
38. The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Lishner M; Slingerland J; Theresa C; Sutcliffe SB
Leuk Lymphoma; 1994 Mar; 13(1-2):131-6. PubMed ID: 7517744
[TBL] [Abstract][Full Text] [Related]
39. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Brice P; Cazals D; Mounier N; Verola O; Neidhart-Berard AM; Remenieras L; Deconinck E; Doyen C; Hamelsand J; Molina T; Moulonguet I; Gisselbrecht C
Leukemia; 1998 Feb; 12(2):213-9. PubMed ID: 9519784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
